<DOC>
	<DOCNO>NCT00638027</DOCNO>
	<brief_summary>Participants ( n=20 ) identify routine care visit perform Rochester Multiple Sclerosis Center . Eligible participant MS McDonald Criteria,7 modify Ashworth spasticity rating8 two high least one low extremity muscle group . Participants see screen , one , three month , evaluate use modify Ashworth scale,8 pendulum test,9 toe tap test,10 manual muscle testing,11 time 25 foot walk,12 Multiple Sclerosis Functional Composite.13 The type severity adverse event record use standard definition . Participants instruct call visit inform investigator regard adverse event experience . Follow-up continue adverse event resolve stabilize .</brief_summary>
	<brief_title>Memantine Spasticity MS Patients</brief_title>
	<detailed_description>This randomize , placebo control , double-blind , parallel group trial memantine patient MS spasticity . Participants identify routine care visit Rochester Multiple Sclerosis Center . After obtain informed consent , patient undergo screen , include physical/neurologic exam assessment Expanded Disability Status Scale , spasticity , functional ability . Eligible patient return baseline evaluation , initiate randomly assign study medication , return one three month re-evaluation . The type severity adverse event record use standard definition . Participants instruct call visit inform investigator regard adverse event experience . Follow-up continue adverse event resolve stabilize .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>1 . Multiple sclerosis McDonald Criteria . 2 . Spasticity . A minimum score two Ashworth spasticity scale least one low extremity muscle group total score least four low extremity muscle test . 3 . Age 1870 . 4 . Normal renal function ( estimate CrCl &gt; 50 ml/min ) . 5 . Women childbearing potential ( i.e. , postmenopausal surgically sterile ) may participate provide use adequate birth control method ( include barrier method , IUD , oral contraceptive ) duration study . 6 . Willing able perform procedure related clinical trial provide inform consent . 1 . Evidence clinically significant thyroid , gastrointestinal , cardiovascular , hepatic , renal , hematologic , respiratory , neoplastic , endocrine ( include diabetes mellitus ) , neurologic ( MS ) , medical psychiatric disorder screening . 2 . Women must pregnant lactating . Serum urine pregnancy test require prior randomization woman childbearing potential unless last menstrual period start less 28 day prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>multiple sclerosis</keyword>
</DOC>